SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-075573
Filing Date
2019-12-23
Accepted
2019-12-23 16:01:15
Documents
6
Period of Report
2019-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1927301-1_8k.htm 8-K 33490
2 EXHIBIT 3.1 tm1927301d1_ex3-1.htm EX-3.1 97896
3 EXHIBIT 4.1 tm1927301d1_ex4-1.htm EX-4.1 123756
4 EXHIBIT 10.1 tm1927301d1_ex10-1.htm EX-10.1 562903
5 EXHIBIT 99.1 tm1927301d1_ex99-1.htm EX-99.1 12656
6 GRAPHIC tm1927301-1img01.jpg GRAPHIC 9098
  Complete submission text file 0001104659-19-075573.txt   844813
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 191305938
SIC: 2836 Biological Products, (No Diagnostic Substances)